Interactions with many clinically active therapeutic agents with deoxyribonucleic acid (DNA) are well studied and it expedites deciphering the structure of DNA and to investigate the pathological implication of those molecules in a living organism. The interaction of dextromethorphan hydrobromide (DEX) with calf thymus DNA (ct DNA) was studied employing UV absorption and fluorescence spectroscopic techniques. The binding affinity of DEX to DNA was calculated at different temperatures and the stoichiometry of binding was characterized to be about 1 dextromethorphan molecule per nucleotide. Hypochromic effect was found in the absorption spectra of dextromethorphan, and its wavelength had no shift in the presence of DNA indicating external binding mode of dextromethorphan to DNA. Quenching constants 3532 L/ mol and 12446L/ mol at 298 K and 308 K respectively with correlation co-efficient of 0.974 and 0.976, using SternVolmer equation and the quenching mechanism was found to be dynamic. Fluorescence spectroscopic results showed the quenching of fluorescence intensity of DEX in the presence of DNA, indicating the interaction between DEX and DNA. Based on this, hydrophobic interaction were found to play the dominating role in DEX-DNA binding and those binding forces also indicate the binding site of dextromethorphan to be in the minor groove of DNA.
Introduction
Deoxyribonucleic acids (DNA) are common targets for antiviral, anticancer and antibiotic drugs. The study on the interaction of small molecules with DNA is of great importance in many areas (Ivandini et al., 2007; Ward et al., 1965) . Most of the investigations of the interactions of DNA with small molecules were conducted to elucidate the structure of DNA (Neidle et al., 1997; Geierstanger et al., 1995; Chaires et al., 1996; Coleman et al., 1995; Wemmer et al., 1997) . Some other studies were conducted solely to determine the interactions to observe possible pathological implications in living system with dyes, drugs and toxic chemicals using different spectroscopic methods (Yuan et al., 1998; Ran et al., 2007; Li et al., 2009) . It is significant not only in understanding the mechanism of interaction, but also for guiding the design of new drugs. So it is necessary to understand the modes and the factors affecting the binding of small molecules to DNA (Singh et al., 1992) . Studying the binding mechanism is of great importance in terms of life science, chemicals, pharmaceuticals, and clinical medicines (Bera et al., 2008; Zhao et al., 2003) . Although the exact mode of actions of many clinically proven therapeutic agents is not known, their interactions to DNA are well studied (Coleman et al., 1995) .
Dextromethorphan or (+)-3-methoxy-17-methyl-9α, 13α, 14α-morphinan is the dextrorotatory enantiomer of levomethorphan, which is the methyl ether of levorphanol, both opioid analgesics. It is an uncompetitive N-methyl-D-aspartate receptor (NMDA) receptor antagonist and μ-, δ-, and κ-opioid receptor agonist (Burns et al., 2013; Codd et al., 1995) . Instead of acting as a direct antagonist of the NMDA receptor itself, dextromethorphan likely functions as a pro-drug to its nearly 10-fold more potent metabolite dextromethorphan, and this is the true mediator of its dissociative effects (Chou et al., 1999) . (+)-3-methoxymorphinan, dextromethorphan's other major metabolite, plays role in its effects, but it is not entirely clear (Schmider et al., 1997) .
Various researchers have studied the interaction of small molecules with DNA but there has been no report on the interaction of DNA with dextromethorphan hydrobromide. In this regard, our study on the interaction of dextromethorphan hydrobromide with calf thymus (ct) DNA was a novel approach on this particular case, done by using fluorescence spectroscopy and UV-visible spectroscopy. Ct-DNA was used as DNA model mainly because of its alternate sugar phosphate sequence with lower protein and highly polymerized skeleton. Moreover, it is easily available and can be used without further purification.
The aim of this investigation was to divulge the binding characteristics between dextromethorphan and DNA by fluorescence quenching spectroscopy. In this regard Stern-Volmer constant which assumed as equivalent to binding constant and binding points per DNA at different temperatures were determined. Besides, the nature of the binding forces was analyzed based on the calculated thermodynamic parameters like enthalpy change (∆H), entropy change (∆S) and Gibb's free energy (∆G)).
Materials and Method
Reagents and chemicals: Calf-thymus DNA was commercially obtained from Sigma-Aldrich Chemicals Co. (USA) and used without further purification. Its stock solution was prepared by dissolving an appropriate amount of DNA in nuclease free water overnight at a final concentration of 3.35×10 -3 mol/L and stored at 4 ºC. The lyophilized DNA should be reconstituted overnight at 2-8 o C to ensure that all materials go into solution. When the product was fully dissolved, the DNA concentration was determined by measuring its UV absorption at 260 nm using a molar absorption coefficient of 6600 L mol -1 cm -1 (Wang et al., 2007) . Purity of DNA was checked by monitoring the ratio of the absorbance at 260 nm to that at 280 nm. The solution gave a ratio of A260/A280 in the range of 1.8-1.9, indicating that the DNA was sufficiently free from protein (Joly et al., 2016 Apparatus: All fluorescence spectra were recorded on F-7000 spectrophotometer (Hitachi, Japan). The absorbance measurements were performed on a UV-1800 spectrophotometer (Shimadzu, Japan) equipped with 1.0 cm quartz cells. Measurement of pH values of the solutions was performed by using pH meter (Hanna, Portugal).
Procedures

Selection of appropriate concentration of drug:
At first, different concentrations of dextromethorphan hydrobromide were screened in UV spectrophotometer to determine maximum wavelength which was found to be 308 nm. In order to determine the effects of different [DEX] concentration on the interaction of dextromethorphan hydrobromide with ct DNA, a constant concentration of DNA was treated with different concentrations of the drug. Then fluorescence intensities of different concentration of drug were measured at the excitation wavelength of 308 nm in the presence of fixed DNA concentration at 298 K.
Measurement of absorbance:
During absorbance measurement a constant concentration of the drug was treated with increasing concentration of the DNA. In order to observe the effect of DNA on absorption spectra of drug, the absorbance of drug was measured in the presence of different DNA concentrations in 1cm path length matched quartz cells with continuous stirring throughout the course of the titration.
Effect of DNA on the fluorescence spectra of dextromethorphan: Fluorescence spectra of drug in presence of various concentration of DNA were measured at the excitation wavelength of 308 nm. Aliquots of DNA were added to the solution of dextromethorphan hydrobromide in Tris-HCl buffer of pH 7.4 and mixed by stirring the complex for 2-3 minutes.
Fluorescence quenching measurements:
A decrease in intrinsic fluorescence intensity of a fluorophore due to various molecular interactions with other molecules is called fluorescence quenching. Dynamic quenching refers to a process in which the fluorophore and the quencher come into contact during the lifetime of the excited state, whereas static quenching refers to fluorophore -quencher complex formation. To assess the interaction between drug and DNA, the fluorescence quenching data are analyzed by Stern-Volmer equation (Lacowicz et al., 1999) :
Here F0 and F are the fluorescence intensities of drug in the absence and presence of quencher, respectively.
[Q] represents the concentration of quencher and KSV is the Stern-Volmer quenching constant.
Thermodynamic parameters and nature of the binding forces:
The interaction forces between quencher and bio-molecules may include hydrophobic forces, electrostatic interactions, Vander Waals interactions, hydrogen bonds etc. (Papadopoulou et al., 2005) . The thermodynamic parameters namely the enthalpy change, the entropy change and Gibb's free energy are calculated in order to elucidate the interaction forces between the DNA and dextromethorphan. The basic reason for carrying out thermodynamic studies of dextromethorphan -DNA interaction is to determine the factors responsible for overall binding affinity and specificity of the drug (Haq et al., 2002) . The thermodynamic parameters can be determined from the Van't Hoff equation:
ln Ka = -(∆H/RT) + (∆S/R) Where ∆H and ∆S are the enthalpy change and the entropy change respectively; constant Ka is analogous to the Stern-Volmer quenching constants KSV at the corresponding temperature (Sun et al., 2006) , whereas R is the gas constant. The enthalpy change (∆H) and the entropy change (∆S) can be determined from the slope and intercept of the fitted curve of ln KSV against 1/T, respectively. The Gibb's free energy (∆G) can be estimated from the following relationship:
∆G = ∆H -T∆S
Binding constant and binding points: When small molecule bind independently to a set of equivalent sites on a macromolecule, the equilibrium between free and bound molecule is given by the following equation (Wu et al., 2009) : Data analysis: All the data were analyzed by using the software Microsoft Excel (MS Excel. 2013). Effect of DNA on absorption of dextromethorphan: When a small molecule interacts with DNA and forms a new complex, a shift in the absorbance wavelength and/ or a change in the molar absorptivity may occur. In order to determine the effect of increasing concentration of DNA on the absorption spectra of dextromethorphan, the absorption of [DEX] in the presence of different DNA concentrations were measured at the excitation wavelength of 308 nm. Here the interaction of the dextromethorphan with DNA results in changes with hypochromic effect that essentially indicates strong intermolecular interaction (Table 1) . At the same time, no bathochromism (redshift) effect occurs when [DEX] bound to DNA. If the binding of small molecules and DNA involves a typical intercalative mode, a hypocromism effect coupled with obvious bathocromism for the characteristic peaks of the small molecules will be found due to strong stacking between the chromophore and the base pairs of DNA (Long et al., 1990) . Therefore, the hypochromic effect could be the indication of noncovalent groove binding. Table 2 and Table 3 at two different temperatures. Static and dynamic quenching are the two quenching process. In static quenching, formation of non fluorescent complex with quencher molecule is responsible for quenching of fluorescence intensity of a fluorophore, whereas dynamic quenching refers to a process in which the fluorophore and the quencher comes into contact during the lifetime of the excited state (Wang et al., 2006) . They can be distinguished by their different temperature dependence. Higher temperatures can lead to faster diffusion and extended collisional quenching, so KSV increases along with increasing temperature. For static quenching, higher temperatures will typically cause the dissociation of weakly bound complexes and Ksv decreases with increasing solvent temperature.
Results and Discussion
Effect of [DEX] concentration on interaction
The fluorescence quenching data at 298 K and 308 K were plotted according to Stern-Volmer equation (Figure 3 ). Stern-Volmer constant was found to be 3532 L/ mol and 12446 L/ mol at 298 K and 308 K respectively, with correlation co-efficient of 0.974 and 0.976. As the KSV increases with increase of temperature , the probable quenching mechanism of the DEX-DNA binding reaction is due to dynamic quenching instead of static quenching.
Thermodynamic parameters and nature of the binding forces: In order to elucidate the forces responsible for overall binding affinity and specificity of the drug, thermodynamic parameters are calculated.
The value of enthalpy change (∆H) and the entropy change (∆S) were determined from the slope and intercept of the fitted curve of ln KSV against 1/T, respectively (Figure 4) . The Gibb's free energy (∆G) can be estimated from the following relationship: ∆G = ∆H -T∆S Figure 5 . Plot for binding constant and binding points for DEX-DNA system at 298 and 308 K.
The enthalpy change (∆H) and the entropy change (∆S) and Gibb's free energy (∆G) are the main evidence to characterize the binding mode. The value of ∆H, ∆S and ∆G were 87.28KJ/ mol, 361.16 KJ/ mol and -20.34 KJ/ mol respectively. Here the enthalpy change (∆H) and the entropy change (∆S) are positive and the Gibb's free energy (∆G) is negative. The positive ∆S value is considered evidence for typical hydrophobic interaction from the point of H2O structure and positive ∆H implies the possibility of hydrophobic interaction. The negative sign for ∆G indicates the spontaneity of the binding process (Ross et al., 1981) .
Thus, hydrophobic interactions in low dielectric media are present in the DEX-DNA binding. As hydrophobic hydrophilic interaction is involved in the binding of DEX with DNA, so it can be said probably dextromethorphan binds in the minor groove of DNA. (Figure 5 ), binding constant and binding number for dextromethorphan -DNA system were determined. Binding points were found to be 0.691 and 1.554 at 298 K and 308 K respectively. From corresponding binding constant 2×10 2 L/ mol and 2.28×10 6 L/ mol, it was observed that the binding constant increases with the increase in temperature of the DEX-DNA complex resulting in the increase stability of the DEX-DNA complex which proved further that the quenching mechanism of DEX-DNA binding reaction is dynamic. The values of n remained nearly constant at different temperatures. The DEX-DNA mol ratio of the system is 1:1. That means 1 mol of DEX binds with per mol of DNA. From these findings new pharmacological activity of dextromethorphan can be discovered by exploiting its DNA binding property as it binds so significantly with DNA.
Discussion
In this study the nature and magnitude of the interaction of dextromethorphan hydrobromide to DNA was investigated in physiological buffer (pH 7.4) by fluorescence and UV absorption spectroscopy. The fluorescence quenching mechanism usually involves static or dynamic quenching. The experimental results demonstrate that dynamic quenching is involved in the DEX-DNA complex (1:1) formation. The thermodynamic parameters indicated that the interaction between [DEX] and DNA was spontaneous and hydrophobic interactions were present as major forces in the DEX-DNA binding that dominates the minor groove of binding. Similar observation was found in some other studies (Dorraji et al., 2013; Lv et al., 2014; Sultana et al., 2013) .
Conclusion
Fluorescence absorption and quenching of the interaction between dextromethorphan and DNA at two different temperatures was observed in this research work. It showed that, dextromethorphan binds to DNA molecule with high affinity through hydrophobic interaction. The quenching pattern was found to be dynamic in this interaction and it was found that dextromethorphan binds with DNA with a mol ratio of 1 : 1.
